These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 80339)

  • 21. [Effect of 15-methyl-prostaglandin F2 alpha used for dilating the cervix uteri before abortion on endogenous prostaglandin F2 alpha synthesis].
    Goncharova VN; Morozova MS; Razina LG; Manuilova IA; Murashko LE
    Akush Ginekol (Mosk); 1981 Dec; (12):37-8. PubMed ID: 6950671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Termination of early gestation with a single vaginal suppository of (15S)-15-methyl-prostaglandin F2alpha methyl ester.
    Roy S; Brenner PF; Marrs RP; Mishell DR
    Contraception; 1980 Aug; 22(2):137-52. PubMed ID: 7449379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostaglandins for the management of anencephalic pregnancy.
    Thiery M; Parewijck W; Decoster JM
    Prostaglandins; 1981 Feb; 21(2):207-15. PubMed ID: 7221011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of two prostaglandins used to terminate midtrimester pregnancy.
    Gookin KS; White CK; Whitworth NS; Wiser WL; Morrison JC
    South Med J; 1984 Jun; 77(6):717-8, 721. PubMed ID: 6587588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of second trimester abortion: comparison between vaginal 15-methyl-PGF2alpha methyl ester and intra-amniotic PGF2alpha.
    Mandelin M; Kajanoja P
    Prostaglandins; 1978 Dec; 16(6):995-1001. PubMed ID: 748987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-conceptional induction of menses with a single vaginal suppository of (15S)-15-methyl prostaglandin F2 alpha methyl ester.
    Scher J; Jeng DY; Kerenyi TD
    Prostaglandins; 1980 Sep; 20(3):469-79. PubMed ID: 6252575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic use of meternal serum alpha-fetoprotein levels.
    Cowchock FS; Jackson LG
    Obstet Gynecol; 1976 Jan; 47(1):63-8. PubMed ID: 54892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated maternal serum alpha-fetoprotein levels associated with breakdown in fetal-maternal-placental barrier.
    Berkeley AS; Killackey MA; Cederqvist LL
    Am J Obstet Gynecol; 1983 Aug; 146(7):859-61. PubMed ID: 6191572
    [No Abstract]   [Full Text] [Related]  

  • 29. Prostaglandin analogues and their uses.
    Bygdeman M
    Baillieres Clin Obstet Gynaecol; 1992 Dec; 6(4):893-903. PubMed ID: 1478002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Raised maternal serum-alpha-fetoprotein levels and spontaneous fetomaternal transfusion.
    Los FJ; de Wolf BT; Huisjes HJ
    Lancet; 1979 Dec; 2(8154):1210-2. PubMed ID: 92622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Blood coagulation tests in prostaglandin F-2alpha induced and a one-time mechanically induced therapeutic abortion].
    Junge WD; Göretzlehner G; Klausch B; Töwe J
    Zentralbl Gynakol; 1974 Aug; 96(35):1116-20. PubMed ID: 4440311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraamniotic 15(s)-15-methyl prostaglandin F2 alpha and termination of middle and late second-trimester pregnancy for genetic indications: a contemporary approach.
    Ferguson JE; Burkett BJ; Pinkerton JV; Thiagarajah S; Flather MM; Martel MM; Hogge WA
    Am J Obstet Gynecol; 1993 Aug; 169(2 Pt 1):332-9; discussion 339-40. PubMed ID: 8362944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostaglandins and abortion. II. Single extra-amniotic administration of 0.92 mg. of 15-methyl prostaglandin F2alpha in Hyskon for termination of pregnancies in weeks 10 to 20 of gestation: an international multicenter study. World Health Organization Task Force on the Use of Prostaglandins for the Regulation of Fertility.
    Am J Obstet Gynecol; 1977 Nov; 129(6):597-600. PubMed ID: 920760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha-fetoprotein levels in maternal plasma and amniotic fluid during prostaglandin-induced mid-trimester abortions: the relation to fetal distress and death.
    Ward RH; Whyley GA; Fairweather DV; Thomas G; Chard T
    Br J Obstet Gynaecol; 1976 Apr; 83(4):299-302. PubMed ID: 57797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Midtrimester abortion: techniques and complications.
    LaFerla JJ
    Clin Perinatol; 1983 Jun; 10(2):305-20. PubMed ID: 6413116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maternal serum and amniotic fluid alpha-fetoprotein as a marker of acute fetal distress in a midtrimester abortion model.
    Weiss RR; Macri JN; Robins J; Elligers KW
    Obstet Gynecol; 1976 Dec; 48(6):718-22. PubMed ID: 63108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Termination of molar pregnancy by intramuscular administration of 15(S)-15-methyl-prostaglandin F2 alpha.
    Keirse MJ
    Prostaglandins Med; 1980 May; 4(5):333-9. PubMed ID: 7403332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Blood coagulation studies of therapeutic abortion induced by 15-methyl-prostaglandin F2 alpha].
    During R; Mauck I; Schwarzlos G
    Zentralbl Gynakol; 1977; 99(22):1361-5. PubMed ID: 602504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early pregnancy termination: a comparison between vacuum aspiration and medical abortion using prostaglandin (16,16 dimethyl-trans-delta 2-PGE1 methyl ester) or the antiprogestogen RU 486.
    Cameron IT; Baird DT
    Br J Obstet Gynaecol; 1988 Mar; 95(3):271-6. PubMed ID: 3370199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cervical dilatation in late first trimester termination by prostaglandin, hylase and isogel.
    Mandlekar AV; Ganguli AC; Krishna UR; Purandare VN
    Prostaglandins Med; 1981 Apr; 6(4):381-7. PubMed ID: 7025067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.